Oslo-based cancer company Algeta has signed a USD 800 million global development and commercialization deal with Bayer, the German multinational pharma company, for its lead product candidate Alpharadin.This is probably the biggest deal made in Norwegian biotech industry in recent history.

Lance Armstrong literally rode into town in late August to help raise cancer awareness at the joint request of Oslo Cancer Cluster, the City of Oslo and the Norwegian Cancer Charity.

The official opening of the new research building at the Norwegian Radium Hospital took place on Thursday August 27th.

The first European Cancer Cluster Partnering Conference (ECCP) closed to almost unanimous acclaim. Held over two days in Toulouse and jointly organized by Oslo Cancer Cluster and Cancer BioSante, the conference focused exclusively on the challenges of translational oncology, bringing together a unique mix of researchers, companies – both biotech’s and big pharma - and investors.

The latest news from BerGenBio, Gamma Medica, Affitech, PCI Biotech Holding, Lytix Biopharma, Clavis Pharma, Nextera and Photocure.

The Norwegian medtech elite met recently at Innovation in Healthcare, a one-day conference organised by Innovation Norway to explore the opportunities and challenges internationalisation poses. Keynote speakers were legendary entrepreneur and personalised medicine prophet Steven Burrill and one of Norway’s leading medtech “exports”, Orn Stuge of Medtronic.

Oncology research is growing strongly in Norway and Hanna Nemchenko is just one of the bright young researchers who has moved to Oslo. She is also among the first to enrol in special business-orientated courses promoted by Oslo Cancer Cluster and others to provide a new generation of bio-entrepreneurs. Originally from the Ukraine, she explains her course and shares impressions of the country.

One to watch: Genetic Analysis
According to Hippocrates, all disease is related to the gut. However, currently there is no comprehensive test that can give you a picture of the composition of the bugs and be able to correlate that to diseases. New Oslo start-up Genetic Analysis aims to change that!

Meet representatives from the Oslo life science sector at the following events: